These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2341048)

  • 21. Anti-OX40 monoclonal antibody therapy in combination with radiotherapy results in therapeutic antitumor immunity to murine lung cancer.
    Yokouchi H; Yamazaki K; Chamoto K; Kikuchi E; Shinagawa N; Oizumi S; Hommura F; Nishimura T; Nishimura M
    Cancer Sci; 2008 Feb; 99(2):361-7. PubMed ID: 18201271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo activities of monoclonal antibody-alkaline phosphatase conjugates in combination with phenol mustard phosphate.
    Wallace PM; Senter PD
    Bioconjug Chem; 1991; 2(5):349-52. PubMed ID: 1790175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts.
    Wilder RB; Langmuir VK; Mendonca HL; Goris ML; Knox SJ
    Cancer Res; 1993 Jul; 53(13):3022-7. PubMed ID: 8319209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Targeting chemotherapy of colorectal cancer by monoclonal antibody conjugated antitumor drug].
    Yamaguchi T; Takahashi T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1060-4. PubMed ID: 2968778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer.
    Utsugi T; Shibata J; Sugimoto Y; Aoyagi K; Wierzba K; Kobunai T; Terada T; Oh-hara T; Tsuruo T; Yamada Y
    Cancer Res; 1996 Jun; 56(12):2809-14. PubMed ID: 8665518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of a conjugate between anti-carcinoembryonic antigen monoclonal antibody and alkaline phosphatase for specific activation of the prodrug etoposide phosphate.
    Haisma HJ; Boven E; van Muijen M; De Vries R; Pinedo HM
    Cancer Immunol Immunother; 1992; 34(5):343-8. PubMed ID: 1540981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo.
    Thorpe PE; Brown AN; Bremner JA; Foxwell BM; Stirpe F
    J Natl Cancer Inst; 1985 Jul; 75(1):151-9. PubMed ID: 3859688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic effects of monoclonal antibody-beta-lactamase conjugates in combination with a nitrogen mustard anticancer prodrug in models of human renal cell carcinoma.
    Svensson HP; Frank IS; Berry KK; Senter PD
    J Med Chem; 1998 Apr; 41(9):1507-12. PubMed ID: 9554883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
    Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ
    Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee study.
    Porter D; Boddy A; Thomas H; Lind M; Newell D; Calvert AH; Robson L; Brampton M; Abrahamsen D; Winograd B
    Semin Oncol; 1996 Dec; 23(6 Suppl 13):34-44. PubMed ID: 8996574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor activity of carcinoma-reactive BR96-doxorubicin conjugate against human carcinomas in athymic mice and rats and syngeneic rat carcinomas in immunocompetent rats.
    Sjögren HO; Isaksson M; Willner D; Hellström I; Hellström KE; Trail PA
    Cancer Res; 1997 Oct; 57(20):4530-6. PubMed ID: 9377565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody-directed enzyme prodrug therapy (ADEPT) with mustard prodrugs.
    Springer CJ; Niculescu-Duvaz I
    Anticancer Drug Des; 1995 Jul; 10(5):361-72. PubMed ID: 7639927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sarah Cannon Cancer Center Consensus Conference on Novel Developments with Podophyllotoxin Therapy.
    Semin Oncol; 1996 Dec; 23(6 Suppl 13):1-60. PubMed ID: 9011942
    [No Abstract]   [Full Text] [Related]  

  • 34. Conjugation of the monoclonal antibody 17-1A with the nitroacridine compound C921 with the poly-L-lysine as an intermediate agent.
    Paprocka M; Boratyński J; Duś D; Kuśnierczyk H; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1997; 45(4):343-9. PubMed ID: 9523011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation, phototoxicity and biodistribution studies of anti-carcinoembryonic antigen monoclonal antibody-phthalocyanine conjugates.
    Carcenac M; Larroque C; Langlois R; van Lier JE; Artus JC; Pèlegrin A
    Photochem Photobiol; 1999 Dec; 70(6):930-6. PubMed ID: 10628305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative antitumor properties in rodents of irreversible inhibitors of L-ornithine decarboxylase, used as such or as prodrugs.
    Claverie N; Mamont PS
    Cancer Res; 1989 Aug; 49(16):4466-71. PubMed ID: 2501026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Targeting therapy of cancer using monoclonal antibody-antitumor drug conjugate].
    Yachi A; Imai K; Hirata H; Hishikawa N
    Nihon Rinsho; 1989 Jun; 47(6):1391-5. PubMed ID: 2475654
    [No Abstract]   [Full Text] [Related]  

  • 38. Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin a-4 3-O-phosphate.
    Pedley RB; Hill SA; Boxer GM; Flynn AA; Boden R; Watson R; Dearling J; Chaplin DJ; Begent RH
    Cancer Res; 2001 Jun; 61(12):4716-22. PubMed ID: 11406542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-monoclonal antibody conjugates for cancer therapy: potentials and limitations.
    Pimm MV
    Crit Rev Ther Drug Carrier Syst; 1988; 5(3):189-227. PubMed ID: 3060267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination antitumor therapy with rabbit tumor necrosis factor and chemo- and immuno-therapeutic agents against murine tumors.
    Gatanaga T; Takahashi K; Yamazaki M; Mizuno D; Abe S
    Jpn J Cancer Res; 1985 Jul; 76(7):631-6. PubMed ID: 3928560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.